Evaluation of a Neurokinin-1 Antagonist in Preventing Multiple-day Cisplatin-induced Nausea and Vomiting

por Li, Quanfu, Wang, Wenjuan, Chen, Gang, Deng, Shuqin, Jiang, Caihong, Chen, Feng, Zhao, Jun, Li, Hui, Bai, Xiaojun, Hu, Yuliang, Da, Lenggaowa, Wu, Yungaowa, Jin, Gaowa
Publicado 2018

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV

por Jin, Yilan, Jin, Gaowa, Zhao, Jun, Jiang, Caihong, Zhao, Lanzhen, Jiang, Ying, Chen, Feng, Li, Hui, Wang, Wenjuan, Wu, Yungaowa, Liu, Guang, Li, Xiaorong, Gu, Min, Li, Xiaomei, Li, Quanfu
Publicado 2021

Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled...

por Gao, Jiali, Zhao, Jun, Jiang, Caihong, Chen, Feng, Zhao, Lanzhen, Jiang, Ying, Li, Hui, Wang, Wenjuan, Wu, Yungaowa, Jin, Yilan, Da, Lenggaowa, Liu, Guang, Zhang, Yajuan, Li, Hongxia, Zhang, Zewei, Jin, Gaowa, Li, Quanfu
Publicado 2022